Gingival capillary changes and oral motor weakness in juvenile dermatomyositis

Rheumatology

Volumn 49, Issue 10, 2010, Pages 1962-1970

  Savioli, Cynthia ^a   Silva, Clovis A ^a   Fabri, Gisele M C ^a   Kozu, Katia ^a   Campos, Lucia M A ^a   Bonfá, Eloisa ^a   Sallum, Adriana M E ^a   de Siqueira, José T ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Gingiva; Juvenile dermatomyositis; Oral health; Temporomandibular disorders

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHLOROQUINE; CREATINE KINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FRUCTOSE BISPHOSPHATE ALDOLASE; IMMUNOGLOBULIN G; LACTATE DEHYDROGENASE; METHOTREXATE; PREDNISONE;

ARTICLE; CAPILLARY FLOW; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DENTAL HEALTH; DERMATOMYOSITIS; ERYTHEMA; FEMALE; GINGIVA DISEASE; HUMAN; JAW MOVEMENT; JAW OPENING REFLEX; JUVENILE DERMATOMYOSITIS; JUVENILE DERMATOMYSITIS; MALE; MANDIBLE; MUSCLE WEAKNESS; MYOSITIS; PERIODONTAL DISEASE; PERIODONTAL EXAMINATION; PRIORITY JOURNAL; SALIVATION; TELANGIECTASIA; TEMPOROMANDIBULAR JOINT;

ADOLESCENT; AGE FACTORS; CAPILLARIES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DERMATOMYOSITIS; FEMALE; GINGIVA; GINGIVAL DISEASES; HUMANS; MALE; MOUTH; MUSCLE WEAKNESS; TEMPOROMANDIBULAR JOINT DISORDERS; TIME FACTORS;

EID: 77956902289     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq189     Document Type: Article

References (36)

1. Feldman BM, Rider LG, Reed AM, Pachman LM. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 2008;371:2201-12.
2. Gonçalves FG, Chimelli L, Sallum AM, Marie SK, Kiss MH, Ferriani VP. Immunohistological analysis of CD59 and membrane attack complex of complement in muscle in juvenile dermatomyositis. J Rheumatol 2002;29:1301-7.
3. Santiago RA, Silva CA, Caparbo VF, Sallum AM, Pereira RM. Bone mineral apparent density in juvenile dermatomyositis: the role of lean body mass and glucocorticoid use. Scand J Rheumatol 2008;37:40-7.
4. Sallum AM, Kiss MH, Silva CA et al. MHC class I and II expression in juvenile dermatomyositis skeletal muscle. Clin Exp Rheumatol 2009;27:519-26.
5. Márton K, Hermann P, Dankó K, Fejérdy P, Madléna M, Nagy G. Evaluation of oral manifestations and masticatory force in patients with polymiositis and dermatomyositis. J Oral Pathol Med 2005;34:164-9.
6. Ghali FE, Stein LD, Fine JD, Burkes J, McCauliffe DP. Gingival telangiectases, an underappreciated physical sign of juvenile dermatomyositis. Arch Dermatol 1999;135: 1370-4.
7. Dourmishev LA, Dourmishev AL, Schwartz RA. Dermatomyositis: an association of gingival telangiectases and anti Jo-1 antibody in adults. Acta Dermatovenerol Alp Panonica Adriat 2007;16:67-72.
8. Rider LG, Atkinson JC. Images and clinical medicine: gingival and periungual vasculopathy of juvenile dermatomyositis. N Engl J Med 2009;360:e21.
9. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7.
10. Almeida PM, Wickerhauser H. Criteria of ABA (Brazilian Association of Advertisers) and ABIPEME (Brazilian Association of Market Research Institutes). São Paulo, Brazil, 1991:1-29.
11. Siqueira JTT, Teixeira MJ. Orofacial Pain: Diagnosis, Treatment and Quality of Life. Curitiba, Brazil: Maio, 2001.
12. World Health Organization. Oral health surveys: basic methods. 4th edition. Geneva, 1997.
13. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J 1975;25:229-35.
14. O'Leary TJ. The periodontal screening examination. J Periodontol 1967;38:617-4.
15. American Academy of Periodontology. Periodontol record. Ann Periodontol 1999;4:1-6.
16. Helkimo H. Studies on function and dysfunction of the masticatory system II. Index for anamnestic dysfunction and occlusal state. Swed Dent J 1974;67: 101-19.
17. Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomand Disord 1992;6:301-55.
18. Bagheri H, Picault P, Schimit L, Houin G, Berlan M, Montastruc JL. Pharmacokinetic study of yohimbine and its pharmacodynamiceffects on salivary secretion in patients treated with tricyclic antidepressants. Br J Clin Pharmac 1994;37:93-6.
19. Bode RK, Klein-Gitelman MS, Miller ML, Lechman TS, Pachman LM. Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. Arthritis Rheum 2003;49:7-15.
20. Rider LG, Feldman BA, Perez MD et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent and patient global assessments. Arthritis Rheum 1997;40:1976-83.
21. Isenberg DA, Allen E, Farewell V et al. International Myositis and Clinical Studies Group (IMACS) International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology 2004;43: 49-54.
22. Lovell DJ, Lindslev CB, Rennebohm RM et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum 1999; 42:2213-9.
23. Legg AT, Merril JB. Physical therapy in infantile paralysis. In: Mock HE, Pemberton R, Caulter J, eds. Principles and practices of physical therapy. Hagerstown, MD: WF Prior, 1932:45-71.
24. Hugoson A, Koch G, Rylander H. Prevalence and distribution of gingivitis-periodontitis in children and adolescents. Epidemiological data as a base for risk group selection. Swed Dent J 1981;5:91-103.
25. Johnson GK, Guthmiller JM. The impact of cigarette smoking on periodontal disease and treatment. Periodontology 2000. 2007;44:178-194.
26. Peres KG, Peres MA, Araujo CL, Menezes AM, Hallal PC. Social and dental status along the life course and oral health impacts in adolescents: a population-based birth cohort. Health Qual Life Outcomes 2009;7:95.
27. Downer MC. Changing trends in dental caries experience in Great Britain. Adv Dent Res 1993;7:19-24.
28. Hobdell MH, Myburgh NG, Kelman M, Hausen H. Setting global goals for oral health for the year 2010. Int Dent J 2000;50:245-9.
29. Savioli C, Silva CA, Ching LH, Campos LM, Prado EF, Siqueira JT. Dental and facial characteristics in patients with juvenile idiophatic arthritis. Rev Hosp Clin Fac Med São Paulo 2004;59:93-8.
30. Fernandes EG, Savioli C, Siqueira JT, Silva CA. Oral health and the masticatory system in juvenile systemic lupus erythematosus. Lupus 2007;16:713-9.
31. Shiboski CH, Krishnan S, Besten PD et al. Gingival enlargement in pediatric organ transplant recipients in relation to tacrolimus-based immunosuppressive regimens. Pediatr Dent 2009;31:38-46.
32. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
33. Pastor-Nieto MA, Kilmurray LG, López-Chumillas A et al. [Methotrexate-associated lymphoproliferative disorder presenting as oral ulcers in a patient with rheumatoid arthritis]. Actas Dermosifiliogr 2009;100: 142-6.
34. Kalantzis A, Marshman Z, Falconer DT, Morgan PR, Odell EW. Oral effects of low-dose methotrexate treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100:52-62.
35. Scully C, Felix DH. Oral Medicine-update for the dental practitioner: oral white patches. Br Dent J 2005;199: 565-72.
36. Christen-Zaech S, Seshadri R, Sundberg J, Paller AS, Pachman LM. Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis. Arthritis Rheum 2008;2:571-6.